Narrow search
Showing 1 - 10 of 6,811
Cover Image
Implications of Indian IP policy on patenting activity of pharmaceutical multinational corporations in India
Venkataraman, P.; Bhagwat, Gauri; Deshpande, Vasanti; … - In: International journal of intellectual property … 8 (2015) 3/4, pp. 249-266
Persistent link: https://www.econbiz.de/10011549498
Cover Image
Harmonization of intellectual property rights across the globe : impact on India's pharmaceutical exports
Bhandarkar, Supriya - 2020
Persistent link: https://www.econbiz.de/10012518985
Cover Image
Measuring the strength of national pharmaceutical intellectual property regimes in eight countries : using a pharmaceutical IP index to benchmark India
Pugatch, Meir Perez - In: The journal of world investment & trade : law, … 8 (2007) 4, pp. 573-591
Persistent link: https://www.econbiz.de/10003555734
Cover Image
Pharmaceutical Patents and Expropriation in Indian Bilateral Investment Treaties
Ranjan, Prabhash - 2017
This chapter discusses whether foreign investors, specifically pharmaceutical companies, could challenge India …'s regulatory measures that impact their patents under India's BITs. More specifically, the paper will focus on whether regulatory … expropriation under India's bilateral investment treaties (BITs). The discussion in the chapter shows that pharmaceutical patents …
Persistent link: https://www.econbiz.de/10012959457
Cover Image
The TRIPS agreement and the pharmaceutical industry in India
Kamiike, Atsuko - In: Journal of interdisciplinary economics 32 (2020) 1, pp. 95-113
Persistent link: https://www.econbiz.de/10012161217
Cover Image
Towards more affordable medicine: A proposal to waive certain obligations from the Agreement on TRIPS
Dhar, Biswajit; Gopakumar, K. M. - 2020
pandemic. Using the recently submitted proposal by India and South Africa, discussed by the TRIPS Council in the WTO in October …
Persistent link: https://www.econbiz.de/10012316008
Cover Image
Big pharma and monopoly capitalism: a long-term view
Dosi, Giovanni; Marengo, Luigi; Staccioli, Jacopo; … - 2021
Are IPRs institutions meant to foster innovative activities or conversely to secure appropriation and profitability? Taking stock of a long-term empirical evidence on the pharmaceutical sector in the US, we can hardly support IPRs intended as an innovation rewarding institution. According to our...
Persistent link: https://www.econbiz.de/10012604733
Cover Image
Access to medicines after TRIPS : is compulsory licensing an effective mechanism to lower drug prices? ; a review of the existing evidence
Urias, Eduardo; Ramani, Shyama V. - In: Journal of International Business Policy : JIBP 3 (2020) 4, pp. 367-384
Persistent link: https://www.econbiz.de/10012405471
Cover Image
Foreign direct investment spillovers and pharmaceutical innovation : the role of intellectual property rights
Ho, Chun-Yu; Li, Xin; Zhou, Weimin - 2017
This paper examines the effect of foreign direct investment (FDI) on domestic innovation based on a data set covering the pharmaceutical industries across 29 provinces in the People's Republic of China (PRC) over the period 1998-2007. We show that there is a negative horizontal spillover effect...
Persistent link: https://www.econbiz.de/10011723712